BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 28, 2000
View Archived Issues
MedImmune reports significant progress during second quarter
Read More
Acetylcysteine useful in preventing contrast agent-induced reductions in renal function
Read More
IB-367 active against microflora associated with oral mucositis
Read More
Sitaxsentan causes selective pulmonary vasodilatation in chronic heart failure
Read More
Antiviral action of aciclovir lipid prodrug assessed against woodchuck hepatitis virus
Read More
Atrix rapidly enrolls patients in clinical trials
Read More
Phase II SBIR grant awarded to Aurora for immunomodulatory drug discovery
Read More
Potent new inhibitor of p210Bcr-Abl tyrosine kinase with selectivity for Bcr-Abl-positive leukemia
Read More
Novel cell adhesion inhibitor acting independently of NF-kappaB identified by Kowa
Read More
TxA2 antagonism and antiplatelet effects of new torasemide derivative BM-531
Read More
Alza, Crescendo report substantial progress this year
Read More
Trial in healthy subjects confirms safety and pharmacological effects of TF-505
Read More
New immunomodulator promising for the management of HIV/AIDS
Read More
Bexxar enters phase II trial for intermediate-grade NHL
Read More
VRCTC-310-Onco enhances serum antiinflammatory cytokine production in humans
Read More
Maxygen and Karolinska Institute to develop novel allergy therapeutics
Read More
Cubist ready to commence further phase III trials of Cidecin
Read More
Pharmacia drops leridistim research program
Read More
TNF-alpha inhibitors and use in therapy of joint inflammation, asthma
Read More
New dosage form, indication approved for Bayer's cerivastatin
Read More
Promising phase Ib results shown for Isotechnika's ISAtx-247
Read More
Recently issued patent covers new nicotinic acetylcholine receptor antagonists
Read More
AstraZeneca presents novel antiinflammatory compounds for asthma, etc.
Read More
Nonpeptide GLP-1 antagonists and their potential uses described in recent patent
Read More
Novel classes of calcium-activated SK/IK/BK channel modulators designed at NeuroSearch
Read More
New inhibitors of Ras oncogene farnesylation in the Merck pipeline
Read More
Antex evaluates dosing schedule in phase Ib/II trial of Helivax
Read More